Part A: Skin inflammatory response measurement as induration by the ball point pen technique Over a four day period after challenge [clinicaltrials_resource:2698feb0b6180b440839b500fc6e2451]

Part A: Skin inflammatory response measurement as induration by the ball point pen technique Over a four day period after challenge [clinicaltrials_resource:2698feb0b6180b440839b500fc6e2451]

The induration of wheals (defined as elevation and induration that are palpable in the skin) that develop as a result of intradermal immunisation with KLH or PPD will be measured in the vertical and horizontal plane using the ball point pen technique. The diameter of the induration will be measured by rolling a medium ball point pen from 10 to 20 millimetre (mm) outside the edge of the induration and toward the centre with just enough pressure to indent the skin slightly.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:2698feb0b6180b440839b500fc6e2451
Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD) [clinicaltrials:NCT01910662]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Part A: Skin inflammatory response measurement as induration by the ball point pen technique Over a four day period after challenge [clinicaltrials_resource:2698feb0b6180b440839b500fc6e2451]

The induration of wheals (defined as elevation and induration that are palpable in the skin) that develop as a result of intradermal immunisation with KLH or PPD will be measured in the vertical and horizontal plane using the ball point pen technique. The diameter of the induration will be measured by rolling a medium ball point pen from 10 to 20 millimetre (mm) outside the edge of the induration and toward the centre with just enough pressure to indent the skin slightly.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:2698feb0b6180b440839b500fc6e2451
Bio2RDF identifier
2698feb0b6180b440839b500fc6e2451
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2698feb0b6180b440839b500fc6e2451
measure [clinicaltrials_vocabulary:measure]
Part A: Skin inflammatory resp ...... y the ball point pen technique
time frame [clinicaltrials_vocabulary:time-frame]
Over a four day period after challenge
description
The induration of wheals (defi ...... e to indent the skin slightly.
identifier
clinicaltrials_resource:2698feb0b6180b440839b500fc6e2451
title
Part A: Skin inflammatory resp ...... our day period after challenge
@en
inDataset
type
label
Part A: Skin inflammatory resp ...... 8feb0b6180b440839b500fc6e2451]
@en